Steven Cohen's position in Foghorn Therapeutics is currently worth $2.88 Million. That's 0.01% of their equity portfolio (641st largest holding). The first Foghorn Therapeutics trade was made in Q1 2021. Since then Steven Cohen bought shares seven more times and sold shares on seven occasions. The investor's estimated purchase price is $3.93 Million, resulting in a loss of 27%.